Immunogenicity, Safety, and Reactogenicity of the 10-valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine and DTPa-IPV-Hib When Coadministered as a 3-dose Primary Vaccination Schedule in the Netherlands: A Randomized Controlled Trial.

M.R. van den Bergh; J. Spijkerman; N. Francois; K. Swinnen; D. Borys; L. Schuerman; R. Veenhoven; E.A.M. Sanders

Immunogenicity, Safety, and Reactogenicity of the 10-valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine and DTPa-IPV-Hib When Coadministered as a 3-dose Primary Vaccination Schedule in the Netherlands: A Randomized Controlled Trial.

M.R. van den Bergh
, J. Spijkerman
, N. Francois
, K. Swinnen
, D. Borys
, L. Schuerman
, R. Veenhoven
, E.A.M. Sanders

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	E170-E178
Number of pages	9
Journal	Pediatric Allergy and Immunology
Volume	30
Issue number	9
Publication status	Published - 2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

http://www.ncbi.nlm.nih.gov/pubmed/21487327

Cite this

van den Bergh, M. R., Spijkerman, J., Francois, N., Swinnen, K., Borys, D., Schuerman, L., Veenhoven, R., & Sanders, E. A. M. (2011). Immunogenicity, Safety, and Reactogenicity of the 10-valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine and DTPa-IPV-Hib When Coadministered as a 3-dose Primary Vaccination Schedule in the Netherlands: A Randomized Controlled Trial. Pediatric Allergy and Immunology, 30(9), E170-E178. http://www.ncbi.nlm.nih.gov/pubmed/21487327

van den Bergh, M.R. ; Spijkerman, J. ; Francois, N. et al. / Immunogenicity, Safety, and Reactogenicity of the 10-valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine and DTPa-IPV-Hib When Coadministered as a 3-dose Primary Vaccination Schedule in the Netherlands: A Randomized Controlled Trial. In: Pediatric Allergy and Immunology. 2011 ; Vol. 30, No. 9. pp. E170-E178.

@article{17b87654042e4b49b1f2def783a3ce09,

title = "Immunogenicity, Safety, and Reactogenicity of the 10-valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine and DTPa-IPV-Hib When Coadministered as a 3-dose Primary Vaccination Schedule in the Netherlands: A Randomized Controlled Trial.",

author = "\{van den Bergh\}, M.R. and J. Spijkerman and N. Francois and K. Swinnen and D. Borys and L. Schuerman and R. Veenhoven and E.A.M. Sanders",

year = "2011",

language = "English",

volume = "30",

pages = "E170--E178",

journal = "Pediatric Allergy and Immunology",

issn = "0905-6157",

publisher = "Blackwell Munksgaard",

number = "9",

}

van den Bergh, MR, Spijkerman, J, Francois, N, Swinnen, K, Borys, D, Schuerman, L, Veenhoven, R & Sanders, EAM 2011, 'Immunogenicity, Safety, and Reactogenicity of the 10-valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine and DTPa-IPV-Hib When Coadministered as a 3-dose Primary Vaccination Schedule in the Netherlands: A Randomized Controlled Trial.', Pediatric Allergy and Immunology, vol. 30, no. 9, pp. E170-E178. <http://www.ncbi.nlm.nih.gov/pubmed/21487327>

Immunogenicity, Safety, and Reactogenicity of the 10-valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine and DTPa-IPV-Hib When Coadministered as a 3-dose Primary Vaccination Schedule in the Netherlands: A Randomized Controlled Trial. / van den Bergh, M.R.; Spijkerman, J.; Francois, N. et al.
In: Pediatric Allergy and Immunology, Vol. 30, No. 9, 2011, p. E170-E178.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Immunogenicity, Safety, and Reactogenicity of the 10-valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine and DTPa-IPV-Hib When Coadministered as a 3-dose Primary Vaccination Schedule in the Netherlands: A Randomized Controlled Trial.

AU - van den Bergh, M.R.

AU - Spijkerman, J.

AU - Francois, N.

AU - Swinnen, K.

AU - Borys, D.

AU - Schuerman, L.

AU - Veenhoven, R.

AU - Sanders, E.A.M.

PY - 2011

Y1 - 2011

M3 - Article

SN - 0905-6157

VL - 30

SP - E170-E178

JO - Pediatric Allergy and Immunology

JF - Pediatric Allergy and Immunology

IS - 9

ER -

van den Bergh MR, Spijkerman J, Francois N, Swinnen K, Borys D, Schuerman L et al. Immunogenicity, Safety, and Reactogenicity of the 10-valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine and DTPa-IPV-Hib When Coadministered as a 3-dose Primary Vaccination Schedule in the Netherlands: A Randomized Controlled Trial. Pediatric Allergy and Immunology. 2011;30(9):E170-E178.